G. Mark Jeffery

461 total citations
17 papers, 320 citations indexed

About

G. Mark Jeffery is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, G. Mark Jeffery has authored 17 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in G. Mark Jeffery's work include Lymphoma Diagnosis and Treatment (4 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Antifungal resistance and susceptibility (2 papers). G. Mark Jeffery is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Antifungal resistance and susceptibility (2 papers). G. Mark Jeffery collaborates with scholars based in New Zealand, United Kingdom and Australia. G. Mark Jeffery's co-authors include Graham M. Mead, Derek N.J. Hart, Jeffrey Theaker, R. M. Blaquiére, Christopher J. Smart, Rosemary Ikram, Michael Beard, Mona Schousboe, D. C. Heaton and J. M. A. Whitehouse and has published in prestigious journals such as Cancer, The American Journal of Medicine and British Journal of Cancer.

In The Last Decade

G. Mark Jeffery

17 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Mark Jeffery New Zealand	10	110	92	72	72	65	17	320
Biswajit Dey India	8	65 0.6×	67 0.7×	50 0.7×	49 0.7×	29 0.4×	88	265
Jin Heon Lee South Korea	12	204 1.9×	102 1.1×	50 0.7×	47 0.7×	80 1.2×	27	419
Jun B. Lee United States	7	194 1.8×	31 0.3×	47 0.7×	75 1.0×	85 1.3×	9	585
Paolo Gattuso United States	8	115 1.0×	57 0.6×	182 2.5×	24 0.3×	59 0.9×	9	383
J.M. Goujon France	11	133 1.2×	63 0.7×	32 0.4×	44 0.6×	39 0.6×	18	430
J Vantelon France	10	41 0.4×	35 0.4×	86 1.2×	18 0.3×	13 0.2×	24	296
Hamayun Imran United States	9	48 0.4×	51 0.6×	62 0.9×	103 1.4×	60 0.9×	25	389
Priya Patel United States	5	53 0.5×	30 0.3×	22 0.3×	38 0.5×	79 1.2×	10	239
Jiraporn Srinakarin Thailand	9	62 0.6×	58 0.6×	118 1.6×	27 0.4×	50 0.8×	27	331
Chakshu Gupta United States	11	57 0.5×	86 0.9×	71 1.0×	23 0.3×	78 1.2×	26	318

Countries citing papers authored by G. Mark Jeffery

Since Specialization

Citations

This map shows the geographic impact of G. Mark Jeffery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Mark Jeffery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Mark Jeffery more than expected).

Fields of papers citing papers by G. Mark Jeffery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Mark Jeffery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Mark Jeffery. The network helps show where G. Mark Jeffery may publish in the future.

Co-authorship network of co-authors of G. Mark Jeffery

This figure shows the co-authorship network connecting the top 25 collaborators of G. Mark Jeffery. A scholar is included among the top collaborators of G. Mark Jeffery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Mark Jeffery. G. Mark Jeffery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Segelov, Eva, Wei Wang, Gwo Fuang Ho, et al.. (2023). LBA29 Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial. Annals of Oncology. 34. S1269–S1269. 2 indexed citations

2.

Hidalgo, Manuel, Michael B. Jameson, Alfredo Carrato, et al.. (2014). A Ph 1B Study of the Anti-Cancer Stem Cell Agent Demcizumab (Dem) & Gemcitabine (Gem) +/- Paclitaxel Protein Bound Particles (Nab-Paclitaxel) in Pts with Pancreatic Cancer. Annals of Oncology. 25. iv210–iv210. 5 indexed citations

3.

Harvey, V.J., Katrina Sharples, R. Isaacs, et al.. (2013). A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II. Annals of Oncology. 24(7). 1828–1834. 5 indexed citations

4.

Thomas, Merlin C. & G. Mark Jeffery. (1998). Sister Joseph's nodule in non-Hodgkin's lymphoma. Clinical Oncology. 10(5). 322–323. 5 indexed citations

5.

Wong, C S, et al.. (1998). Endobronchial non-Hodgkin's lymphoma. Respiratory Medicine. 92(7). 975–977. 9 indexed citations

6.

Lee, Gary, C S Wong, & G. Mark Jeffery. (1997). Endobronchial metastasis from rectal adenocarcinoma. Respiratory Medicine. 91(4). 245–248. 8 indexed citations

7.

Jeffery, G. Mark, et al.. (1992). CMV chemotherapy for advanced transitional cell carcinoma. British Journal of Cancer. 66(3). 542–546. 13 indexed citations

8.

Jeffery, G. Mark, et al.. (1991). Involved field radiotherapy or chemotherapy in the management of stage I nodal intermediate grade non-Hodgkin's lymphoma. British Journal of Cancer. 64(5). 933–937. 15 indexed citations

9.

Jeffery, G. Mark, Graham M. Mead, & J. M. A. Whitehouse. (1991). Life-threatening airway obstruction at the presentation of Hodgkin's disease. Cancer. 67(2). 506–510. 26 indexed citations

10.

Jeffery, G. Mark, et al.. (1991). Non-Hodgkin's lymphoma arising in skeletal muscle. Annals of Oncology. 2(7). 501–504. 22 indexed citations

11.

Jeffery, G. Mark, et al.. (1991). The Growing Teratoma Syndrome. British Journal of Urology. 67(2). 195–202. 74 indexed citations

12.

Jeffery, G. Mark, Michael Beard, Rosemary Ikram, et al.. (1991). Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. The American Journal of Medicine. 90(1). 685–692. 26 indexed citations

13.

Jeffery, G. Mark, Michael Beard, Rosemary Ikram, et al.. (1991). Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. The American Journal of Medicine. 90(6). 685–692. 56 indexed citations

14.

Jeffery, G. Mark, Christopher Frampton, Helen Legge, & Derek N.J. Hart. (1990). Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy. Pathology. 22(1). 20–23. 23 indexed citations

15.

Jeffery, G. Mark, B M Colls, Bridget A. Robinson, Bernard M. Fitzharris, & Callum Atkinson. (1989). A risk factor for relapse in Hodgkin's disease: Female gender?. Hematological Oncology. 7(5). 345–353. 5 indexed citations

16.

Robinson, Bridget A., et al.. (1989). Circadian pharmacokinetics of methotrexate. Cancer Chemotherapy and Pharmacology. 24(6). 397–9. 7 indexed citations

17.

Begg, EJ, et al.. (1989). Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations [see comments]. British Journal of Clinical Pharmacology. 28(2). 137–141. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact